---
provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2025-12-29T00:22:29.392521'
end_time: '2025-12-29T00:29:00.234244'
duration_seconds: 390.84
template_file: templates/gene_research_go_focused.md
template_variables:
  organism: human
  gene_id: ISCU
  gene_symbol: ISCU
  uniprot_accession: Q9H1K1
  protein_description: 'RecName: Full=Iron-sulfur cluster assembly enzyme ISCU {ECO:0000305};
    AltName: Full=NifU-like N-terminal domain-containing protein; AltName: Full=NifU-like
    protein; Flags: Precursor;'
  gene_info: Name=ISCU {ECO:0000312|HGNC:HGNC:29882}; Synonyms=NIFUN;
  organism_full: Homo sapiens (Human).
  protein_family: Belongs to the NifU family. .
  protein_domains: ISCU. (IPR011339); NIF_FeS_clus_asmbl_NifU_N. (IPR002871); NifU_N
    (PF01592)
provider_config:
  timeout: 600
  max_retries: 3
  parameters:
    allowed_domains: []
    temperature: 0.1
citation_count: 27
---

## Question

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** Q9H1K1
- **Protein Description:** RecName: Full=Iron-sulfur cluster assembly enzyme ISCU {ECO:0000305}; AltName: Full=NifU-like N-terminal domain-containing protein; AltName: Full=NifU-like protein; Flags: Precursor;
- **Gene Information:** Name=ISCU {ECO:0000312|HGNC:HGNC:29882}; Synonyms=NIFUN;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Belongs to the NifU family. .
- **Key Domains:** ISCU. (IPR011339); NIF_FeS_clus_asmbl_NifU_N. (IPR002871); NifU_N (PF01592)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "ISCU" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'ISCU' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **ISCU** (gene ID: ISCU, UniProt: Q9H1K1) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

## Output

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.

# Gene Research for Functional Annotation

## ⚠️ CRITICAL: Gene/Protein Identification Context

**BEFORE YOU BEGIN RESEARCH:** You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

### Target Gene/Protein Identity (from UniProt):
- **UniProt Accession:** Q9H1K1
- **Protein Description:** RecName: Full=Iron-sulfur cluster assembly enzyme ISCU {ECO:0000305}; AltName: Full=NifU-like N-terminal domain-containing protein; AltName: Full=NifU-like protein; Flags: Precursor;
- **Gene Information:** Name=ISCU {ECO:0000312|HGNC:HGNC:29882}; Synonyms=NIFUN;
- **Organism (full):** Homo sapiens (Human).
- **Protein Family:** Belongs to the NifU family. .
- **Key Domains:** ISCU. (IPR011339); NIF_FeS_clus_asmbl_NifU_N. (IPR002871); NifU_N (PF01592)

### MANDATORY VERIFICATION STEPS:

1. **Check if the gene symbol "ISCU" matches the protein description above**
2. **Verify the organism is correct:** Homo sapiens (Human).
3. **Check if protein family/domains align with what you find in literature**
4. **If you find literature for a DIFFERENT gene with the same or similar symbol, STOP**

### If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

**DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.** Instead:
- State clearly: "The gene symbol 'ISCU' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

### Research Target:

Please provide a comprehensive research report on the gene **ISCU** (gene ID: ISCU, UniProt: Q9H1K1) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Research plan and verification
- Target verification: The query targets human ISCU, UniProt Q9H1K1. Evidence-based sources identify ISCU as the canonical human mitochondrial iron–sulfur (Fe–S) cluster assembly scaffold protein (NifU family) that supports de novo [2Fe–2S] biosynthesis in the mitochondrial matrix, consistent with the UniProt description and NifU-family domain architecture (human) (maio2024ciao1lossof pages 15-16, jain2020assemblyofthe pages 15-16). The core complex membership and mechanistic studies below confirm alignment with the ISCU/ISCU2 scaffold and NifU-like domain features in the human ISC pathway (schulz2024mechanismandstructural pages 1-3, steinhilper2024twostagebindingof pages 1-2).

1) Key concepts and definitions
- Definition: ISCU (human; UniProt Q9H1K1) is the scaffold protein of the mitochondrial iron–sulfur cluster (ISC) assembly machinery upon which a nascent [2Fe–2S] cluster is built from ferrous iron and cysteine-derived sulfur. In mammals, ISCU is the primary platform for de novo [2Fe–2S] assembly in mitochondria (jain2020assemblyofthe pages 15-16, maio2024ciao1lossof pages 15-16). After assembly, the cluster is transferred to recipient apoproteins directly or via intermediate carriers (jain2020assemblyofthe pages 15-16, jain2020assemblyofthe pages 3-4).
- Current understanding: The mitochondrial core ISC complex minimally comprises the NFS1–ISD11(LYRM4)–ACP (NDUFAB1) cysteine-desulfurase subcomplex, the ISCU scaffold, frataxin (FXN) as an allosteric activator, and mitochondrial ferredoxin-2 (FDX2) as the electron donor. High-resolution cryo-EM and biophysical studies have refined the mechanistic steps of persulfide transfer and [2Fe–2S] assembly on ISCU (2024) (schulz2024mechanismandstructural pages 1-3, steinhilper2024twostagebindingof pages 1-2). Release of the [2Fe–2S] cluster for trafficking requires the mitochondrial Hsp70 system HSPA9 with the J-domain co-chaperone HSC20 (heffner2024tipofthe pages 2-4, jain2020assemblyofthe pages 15-16).

2) Recent developments and latest research (priority 2023–2024)
- Persulfide transfer mechanism visualized: 2024 cryo-EM snapshots captured sulfur transfer from Cys381 of NFS1 to the conserved Cys138 of ISCU, demonstrating that Cys138ISCU “rapidly receives the persulfide without a detectable intermediate,” and clarifying frataxin’s role in positioning assembly-site residues to accelerate sulfur transfer. Mössbauer spectroscopy revealed frataxin shifts the equilibrium between pre- and post-sulfur-transfer Fe coordination states during assembly (Nature Communications, 2024; URL: https://doi.org/10.1038/s41467-024-47310-8) (schulz2024mechanismandstructural pages 1-3).
- FDX2’s two-stage binding to the core complex: 2024 structural work showed FDX2 binds the human core ISC complex in two conformations—distal and proximal—that compete with frataxin for overlapping sites. In the proximal conformation, FDX2’s cluster approaches the ISCU assembly site to deliver electrons rapidly; FDX2 is reduced by FDXR/NADPH (Nature Communications, 2024; URL: https://doi.org/10.1038/s41467-024-54585-4) (steinhilper2024twostagebindingof pages 1-2).
- Chaperone-mediated release and delivery: Recent reviews highlight HSC20 recognition of LYR-like motifs in client proteins and its functional interaction with HSPA9 to catalyze ATP-dependent cluster release from holo-ISCU. HSC20 may also connect mitochondrial biogenesis with cytosolic CIA delivery complexes (Inorganics, 2024; URL: https://doi.org/10.20944/preprints202312.1414.v1) (heffner2024tipofthe pages 2-4).

3) Primary function, substrates, and mechanism
- Enzymatic context: ISCU is not a classical enzyme; it is a scaffold that accepts sulfur and iron to assemble a [2Fe–2S] cluster. NFS1 (PLP-dependent) mobilizes sulfur from L-cysteine, forming a persulfide on NFS1 Cys381, which is transferred to ISCU Cys138. FXN optimizes the assembly site for efficient transfer; FDX2 donates electrons to reduce persulfide sulfur to sulfide as [2Fe–2S] forms. Structural data suggest ISCU dimerization assists assembly, potentially by combining two [1Fe–1S] equivalents (Nature Communications, 2024; URLs above) (schulz2024mechanismandstructural pages 1-3, steinhilper2024twostagebindingof pages 1-2). After assembly on ISCU, [2Fe–2S] can be reductively coupled to [4Fe–4S] on downstream carriers (jain2020assemblyofthe pages 3-4, jain2020assemblyofthe pages 15-16).

4) Subcellular localization and isoforms
- Localization: ISCU operates in the mitochondrial matrix as the primary de novo Fe–S assembly scaffold. In human studies, the mitochondrial ISCU/“ISCU2” scaffold is emphasized for de novo synthesis (J Clin Invest, 2024; URL: https://doi.org/10.1172/jci179559; Hum Mol Genet, 2020; URL: https://doi.org/10.1093/hmg/ddaa172) (maio2024ciao1lossof pages 15-16, jain2020assemblyofthe pages 15-16).

5) Pathways and downstream delivery
- Cluster release and delivery to clients: The HSPA9/HSC20 chaperone system recognizes ISCU-bound clusters and LYR-like motifs in recipients, mediating transfer from ISCU to client proteins or to intermediate carriers (Inorganics, 2024; URL above) (heffner2024tipofthe pages 2-4, jain2020assemblyofthe pages 15-16).
- Delivery nodes and maturation logic: Multiple pathways exist. GLRX5 can heterodimerize with BOLA3 holding a bridged [2Fe–2S]; ISCA1/ISCA2 with IBA57 can convert [2Fe–2S] to [4Fe–4S]; NFU1 acts as a late [4Fe–4S] carrier. For NFU1, human genetic/biochemical analysis shows that its [4Fe–4S] forms by coordinated donation of two [2Fe–2S] clusters from ISCU2 and ISCA1, with FDX2 supplying reducing equivalents; NFU1 then donates to targets such as lipoic acid synthase (LIAS) that supports lipoylation of PDH, α-KGDH, and the glycine cleavage complex (Hum Mol Genet, 2020; URL: https://doi.org/10.1093/hmg/ddaa172) (jain2020assemblyofthe pages 3-4, jain2020assemblyofthe pages 15-16, jain2020assemblyofthe pages 2-2, jain2020assemblyofthe pages 9-10, jain2020assemblyofthe pages 19-20).

6) Disease relevance and 2023–2024 clinical context
- ISCU deficiency: A recurrent ISCU splice mutation produces a skeletal muscle–predominant hereditary myopathy with lactic acidosis and exercise intolerance; complete loss of ISCU is embryonic lethal in mice, underscoring its essentiality. Clinical and mechanistic summaries of ISCU deficiency and broader ISC pathway defects were highlighted in 2024 work describing CIAO1 loss-of-function disease where the ISC pathway components (NFS1, LYRM4/ISD11, ACP/NDUFAB1, ISCU, FXN) are central to mitochondrial and nucleocytoplasmic Fe–S biogenesis (J Clin Invest, 2024; URL: https://doi.org/10.1172/jci179559) (maio2024ciao1lossof pages 15-16). Downstream genes (NFU1, ISCA1/2, IBA57, BOLA3) cause multiple mitochondrial dysfunctions syndromes (MMDS) when mutated, reflecting the critical role of post-ISCU delivery nodes (jain2020assemblyofthe pages 3-4, jain2020assemblyofthe pages 15-16).

7) Regulatory aspects
- Chaperone gating: Cluster release from ISCU depends on HSPA9/HSC20, which recognize LYR-like motifs and stimulate transfer by coupling to ATP hydrolysis (Inorganics, 2024; URL above) (heffner2024tipofthe pages 2-4, jain2020assemblyofthe pages 15-16).
- Emerging regulation: Reviews note miRNA and post-translational control as emerging regulatory layers for ISC components in human cells, though detailed, gene-specific regulatory maps for ISCU require further primary evidence beyond the core biogenesis and delivery literature summarized here (heffner2024tipofthe pages 2-4). (Note: specific miRNA–ISCU interactions have been reported in individual disease contexts outside the core mitochondrial literature; confirm gene- and tissue-specificity with primary disease studies before translational use.)

8) Current applications and implementations
- Diagnostics and functional genomics: ISCU’s central role enables genetic diagnosis of hereditary myopathy associated with ISCU splice and other variants. Functional assays tracing Fe–S client activities (e.g., LIAS-dependent lipoylation; SDHB stability) and interaction mapping between ISCU and downstream carriers (NFU1/ISCA1) have been used to validate pathogenic mechanisms and guide interpretation of variants of uncertain significance (Hum Mol Genet, 2020; URL above) (jain2020assemblyofthe pages 3-4, jain2020assemblyofthe pages 15-16, jain2020assemblyofthe pages 2-2, jain2020assemblyofthe pages 9-10, jain2020assemblyofthe pages 19-20).
- Structural biochemistry: 2024 cryo-EM structures of the human core ISC complex provide atomic-level targets and mechanistic points for intervention (e.g., FXN/FDX2 competition at overlapping binding sites; electron delivery geometry), facilitating structure-guided hypotheses in disease and potentially in drug discovery for ISC pathway modulation (Nature Communications, 2024; URLs above) (schulz2024mechanismandstructural pages 1-3, steinhilper2024twostagebindingof pages 1-2).

9) Expert opinions and authoritative synthesis
- The JCI 2024 clinical-genetics study (CIAO1 deficiency) synthesizes the human ISC and CIA systems in disease, explicitly listing ISCU as the initial scaffold central to mitochondrial Fe–S biogenesis. It integrates clinical phenotypes with pathway biology, highlighting the essentiality and tissue dependencies of Fe–S maturation (J Clin Invest, 2024; URL above) (maio2024ciao1lossof pages 15-16).
- The 2024 mechanistic Nature Communications papers (Schulz et al., Steinhilper et al.) provide a consensus on sulfur transfer and electron delivery steps and the roles of FXN and FDX2, reflecting an emerging structural-mechanistic standard for the human ISC field (schulz2024mechanismandstructural pages 1-3, steinhilper2024twostagebindingof pages 1-2).
- Reviews summarizing HSC20/HSPA9-mediated cluster transfer and downstream delivery nodes emphasize the conserved logic of biogenesis and the modularity of handoff to carriers such as GLRX5/BOLA3 and ISCA/NFU1 (Inorganics, 2024; URL above) (heffner2024tipofthe pages 2-4).

10) Quantitative/statistical data points
- Mechanistic kinetics and structural snapshots: Cryo-EM and spectroscopy show sulfur transfer from NFS1 Cys381 to ISCU Cys138 occurs rapidly with no detectable intermediate; FXN shifts Fe coordination equilibria toward post-transfer states (Nature Communications, 2024; URL above) (schulz2024mechanismandstructural pages 1-3).
- Binding dynamics and distances: FDX2 competes with FXN for overlapping sites and binds in distal and proximal conformations; in the proximal state, FDX2 positions its cluster close to the ISCU assembly site to enable rapid electron transfer (Nature Communications, 2024; URL above) (steinhilper2024twostagebindingof pages 1-2).
- Downstream functional readouts: In human cell models, loss of proper downstream delivery (e.g., due to NFU1 variants) decreases LIAS-dependent lipoylation and SDHB abundance, providing quantitative biomarkers of pathway integrity in assays (Hum Mol Genet, 2020; URL above) (jain2020assemblyofthe pages 15-16, jain2020assemblyofthe pages 2-2).

Key facts summary table
| Key point | Summary | Sources (IDs, URLs) |
|---|---|---|
| Identity verification | ISCU (UniProt Q9H1K1) is the human mitochondrial iron–sulfur (Fe–S) cluster scaffold (NifU family) required for de novo [2Fe-2S] assembly. | (maio2024ciao1lossof pages 15-16) https://doi.org/10.1172/jci179559, (solaveraUnknownyearfunctionalcharacterizationof pages 38-40) https://doi.org/10.1093/hmg/ddaa172 |
| Core ISC complex components | Core mitochondrial ISC: NFS1 (cysteine desulfurase)–ISD11/LYRM4–ACP (NDUFAB1) subcomplex, ISCU (scaffold/ISCU2 isoform), frataxin (FXN), and ferredoxin-2 (FDX2). | (schulz2024mechanismandstructural pages 1-3) https://doi.org/10.1038/s41467-024-47310-8, (steinhilper2024twostagebindingof pages 1-2) https://doi.org/10.1038/s41467-024-54585-4 |
| Mechanistic persulfide transfer & [2Fe-2S] assembly | NFS1 (Cys381) forms a persulfide from L-cysteine and transfers sulfur to ISCU (Cys138); ISCU dimerization and delivery of Fe + electrons (via FDX2/FDXR) yields a [2Fe-2S] cluster on ISCU. FXN accelerates/optimizes persulfide transfer and assembly-site geometry. | (schulz2024mechanismandstructural pages 1-3) https://doi.org/10.1038/s41467-024-47310-8, (steinhilper2024twostagebindingof pages 1-2) https://doi.org/10.1038/s41467-024-54585-4 |
| FDX2 two-stage binding & electron donor role | FDX2 binds the core ISC in two conformations (distal/proximal); the proximal state positions FDX2’s cluster/electrons for rapid reduction of persulfide-derived sulfur during [2Fe-2S] formation; FDXR/NADPH reduce FDX2. | (steinhilper2024twostagebindingof pages 1-2) https://doi.org/10.1038/s41467-024-54585-4, (schulz2024mechanismandstructural pages 1-3) https://doi.org/10.1038/s41467-024-47310-8 |
| Frataxin (FXN) role | FXN transiently binds between NFS1 and ISCU to enhance sulfur transfer rates and to modulate Fe coordination dynamics during assembly; dysfunction of FXN is linked to Friedreich ataxia. | (schulz2024mechanismandstructural pages 1-3) https://doi.org/10.1038/s41467-024-47310-8, (heffner2024tipofthe pages 2-4) https://doi.org/10.20944/preprints202312.1414.v1 |
| Release & chaperone-mediated transfer (HSPA9/HSC20) | After assembly, HSPA9 (mito Hsp70) with J-type co-chaperone HSC20 recognizes ISCU and catalyzes cluster release/transfer to recipients or to intermediate carriers; HSC20 recognizes LYR-like motifs in recipients. | (heffner2024tipofthe pages 2-4) https://doi.org/10.20944/preprints202312.1414.v1, (jain2020assemblyofthe pages 15-16) https://doi.org/10.1093/hmg/ddaa172 |
| Downstream delivery nodes | ISCU → GLRX5/BOLA3 (bridged [2Fe-2S] units), ISCA1/ISCA2–IBA57 (assembly of [4Fe-4S]), NFU1 (late [4Fe-4S] carrier); coordinated handoff enables maturation of lipoyl synthase, respiratory complexes, and many mitochondrial clients. | (jain2020assemblyofthe pages 3-4) https://doi.org/10.1093/hmg/ddaa172, (jain2020assemblyofthe pages 15-16) https://doi.org/10.1093/hmg/ddaa172 |
| Subcellular localization / isoforms | Human ISCU functions in the mitochondrial matrix (commonly referenced as mitochondrial ISCU/ISCU2 isoform); evidence supports mitochondrial-localized scaffold as primary site for de novo Fe–S assembly. | (maio2024ciao1lossof pages 15-16) https://doi.org/10.1172/jci179559, (jain2020assemblyofthe pages 15-16) https://doi.org/10.1093/hmg/ddaa172 |
| Regulatory controls (miRNA, PTM) | miRNA-mediated repression (e.g., miR-210 reported to downregulate ISCU in cancer contexts) and post-translational modulation have been reported in the literature as regulatory layers; phosphorylation/degradation control has emerging evidence. (See primary refs for experimental details.) | (solaveraUnknownyearfunctionalcharacterizationof pages 38-40) https://doi.org/10.1093/hmg/ddaa172, (heffner2024tipofthe pages 2-4) https://doi.org/10.20944/preprints202312.1414.v1 |
| Disease connections & variants | Recessive ISCU splice mutation causes hereditary ISCU myopathy (exercise intolerance, lactic acidosis); heterozygous/dominant ISCU variants also reported; defects in downstream carriers (NFU1, ISCA1/2, BOLA3) cause multiple mitochondrial dysfunction syndromes (MMDS). | (maio2024ciao1lossof pages 15-16) https://doi.org/10.1172/jci179559, (jain2020assemblyofthe pages 15-16) https://doi.org/10.1093/hmg/ddaa172 |
| Key 2023–2024 findings | High-resolution cryo-EM and biochemical studies (2024) defined persulfide transfer snapshots (Cys381NFS1 → Cys138ISCU), clarified FXN’s accelerating role, and described FDX2 two-stage binding dynamics; recent clinical genetics reports continue to expand ISCU variant spectrum. | (schulz2024mechanismandstructural pages 1-3) https://doi.org/10.1038/s41467-024-47310-8, (steinhilper2024twostagebindingof pages 1-2) https://doi.org/10.1038/s41467-024-54585-4, (maio2024ciao1lossof pages 15-16) https://doi.org/10.1172/jci179559 |


*Table: Concise reference table summarizing identity, mechanism, partners, localization, regulation, and disease relevance of human ISCU (UniProt Q9H1K1) with source IDs and URLs for the cited evidence.*

Conclusions
Human ISCU (Q9H1K1) is the mitochondrial NifU-family scaffold that initiates Fe–S biogenesis by accepting sulfur from NFS1 and assembling [2Fe–2S] with FXN and FDX2. 2024 structural studies now depict sulfur handover to ISCU Cys138 and the two-stage binding of FDX2 that positions electron transfer for cluster formation. Cluster release from ISCU requires HSPA9/HSC20 for transfer to clients and carriers. Delivery nodes—including GLRX5/BOLA3, ISCA1/ISCA2–IBA57, and NFU1—complete maturation to [4Fe–4S] clusters and insertion into specific client enzymes. ISCU deficiency causes a characteristic hereditary myopathy, and defects in downstream nodes cause MMDS, underscoring the centrality of ISCU in human mitochondrial proteostasis (schulz2024mechanismandstructural pages 1-3, steinhilper2024twostagebindingof pages 1-2, jain2020assemblyofthe pages 15-16, jain2020assemblyofthe pages 3-4, maio2024ciao1lossof pages 15-16, heffner2024tipofthe pages 2-4).

References (with URLs and dates)
- Schulz V et al., 2024, Nature Communications. Mechanism and structural dynamics of sulfur transfer during de novo [2Fe–2S] cluster assembly on ISCU2. https://doi.org/10.1038/s41467-024-47310-8 (Apr 2024) (schulz2024mechanismandstructural pages 1-3).
- Steinhilper R et al., 2024, Nature Communications. Two-stage binding of mitochondrial ferredoxin-2 to the core iron–sulfur cluster assembly complex. https://doi.org/10.1038/s41467-024-54585-4 (Dec 2024) (steinhilper2024twostagebindingof pages 1-2).
- Jain A et al., 2020, Human Molecular Genetics. Assembly of the [4Fe–4S] cluster of NFU1 requires the coordinated donation of two [2Fe–2S] clusters from ISCU2 and ISCA1. https://doi.org/10.1093/hmg/ddaa172 (Aug 2020) (jain2020assemblyofthe pages 3-4, jain2020assemblyofthe pages 15-16, jain2020assemblyofthe pages 2-2, jain2020assemblyofthe pages 9-10, jain2020assemblyofthe pages 19-20).
- Maio N et al., 2024, Journal of Clinical Investigation. CIAO1 loss of function causes a neuromuscular disorder with compromise of nucleocytoplasmic Fe–S enzymes. https://doi.org/10.1172/jci179559 (Jun 2024) (maio2024ciao1lossof pages 15-16).
- Heffner AL, Maio N., 2024, Inorganics. Tip of the Iceberg: A New Wave of Fe–S Proteins Found in Viruses (review with host Fe–S biogenesis overview). https://doi.org/10.20944/preprints202312.1414.v1 (Jan 2024) (heffner2024tipofthe pages 2-4).

References

1. (maio2024ciao1lossof pages 15-16): Nunziata Maio, Rotem Orbach, Irina T. Zaharieva, Ana Töpf, Sandra Donkervoort, Pinki Munot, Juliane Mueller, Tracey Willis, Sumit Verma, Stojan Peric, Deepa Krishnakumar, Sniya Sudhakar, A. Reghan Foley, Sarah Silverstein, Ganka Douglas, Lynn Pais, Stephanie DiTroia, Christopher Grunseich, Ying Hu, Caroline Sewry, Anna Sarkozy, Volker Straub, Francesco Muntoni, Tracey A. Rouault, and Carsten G. Bönnemann. Ciao1 loss of function causes a neuromuscular disorder with compromise of nucleocytoplasmic fe-s enzymes. The Journal of Clinical Investigation, Jun 2024. URL: https://doi.org/10.1172/jci179559, doi:10.1172/jci179559. This article has 13 citations.

2. (jain2020assemblyofthe pages 15-16): Anshika Jain, Anamika Singh, Nunziata Maio, and Tracey A Rouault. Assembly of the [4fe–4s] cluster of nfu1 requires the coordinated donation of two [2fe–2s] clusters from the scaffold proteins, iscu2 and isca1. Human Molecular Genetics, 29:3165-3182, Aug 2020. URL: https://doi.org/10.1093/hmg/ddaa172, doi:10.1093/hmg/ddaa172. This article has 27 citations and is from a domain leading peer-reviewed journal.

3. (schulz2024mechanismandstructural pages 1-3): Vinzent Schulz, Ralf Steinhilper, Jonathan Oltmanns, S. Freibert, Nils Krapoth, Uwe Linne, Sonja Welsch, M. H. Hoock, Volker Schünemann, Bonnie J. Murphy, and Roland Lill. Mechanism and structural dynamics of sulfur transfer during de novo [2fe-2s] cluster assembly on iscu2. Nature Communications, Apr 2024. URL: https://doi.org/10.1038/s41467-024-47310-8, doi:10.1038/s41467-024-47310-8. This article has 21 citations and is from a highest quality peer-reviewed journal.

4. (steinhilper2024twostagebindingof pages 1-2): Ralf Steinhilper, Linda Boß, Sven-A. Freibert, Vinzent Schulz, Nils Krapoth, Susann Kaltwasser, Roland Lill, and Bonnie J. Murphy. Two-stage binding of mitochondrial ferredoxin-2 to the core iron-sulfur cluster assembly complex. Nature Communications, Dec 2024. URL: https://doi.org/10.1038/s41467-024-54585-4, doi:10.1038/s41467-024-54585-4. This article has 21 citations and is from a highest quality peer-reviewed journal.

5. (jain2020assemblyofthe pages 3-4): Anshika Jain, Anamika Singh, Nunziata Maio, and Tracey A Rouault. Assembly of the [4fe–4s] cluster of nfu1 requires the coordinated donation of two [2fe–2s] clusters from the scaffold proteins, iscu2 and isca1. Human Molecular Genetics, 29:3165-3182, Aug 2020. URL: https://doi.org/10.1093/hmg/ddaa172, doi:10.1093/hmg/ddaa172. This article has 27 citations and is from a domain leading peer-reviewed journal.

6. (heffner2024tipofthe pages 2-4): Audrey L. Heffner and Nunziata Maio. Tip of the iceberg: a new wave of iron–sulfur cluster proteins found in viruses. Inorganics, 12:34, Jan 2024. URL: https://doi.org/10.20944/preprints202312.1414.v1, doi:10.20944/preprints202312.1414.v1. This article has 4 citations and is from a poor quality or predatory journal.

7. (jain2020assemblyofthe pages 2-2): Anshika Jain, Anamika Singh, Nunziata Maio, and Tracey A Rouault. Assembly of the [4fe–4s] cluster of nfu1 requires the coordinated donation of two [2fe–2s] clusters from the scaffold proteins, iscu2 and isca1. Human Molecular Genetics, 29:3165-3182, Aug 2020. URL: https://doi.org/10.1093/hmg/ddaa172, doi:10.1093/hmg/ddaa172. This article has 27 citations and is from a domain leading peer-reviewed journal.

8. (jain2020assemblyofthe pages 9-10): Anshika Jain, Anamika Singh, Nunziata Maio, and Tracey A Rouault. Assembly of the [4fe–4s] cluster of nfu1 requires the coordinated donation of two [2fe–2s] clusters from the scaffold proteins, iscu2 and isca1. Human Molecular Genetics, 29:3165-3182, Aug 2020. URL: https://doi.org/10.1093/hmg/ddaa172, doi:10.1093/hmg/ddaa172. This article has 27 citations and is from a domain leading peer-reviewed journal.

9. (jain2020assemblyofthe pages 19-20): Anshika Jain, Anamika Singh, Nunziata Maio, and Tracey A Rouault. Assembly of the [4fe–4s] cluster of nfu1 requires the coordinated donation of two [2fe–2s] clusters from the scaffold proteins, iscu2 and isca1. Human Molecular Genetics, 29:3165-3182, Aug 2020. URL: https://doi.org/10.1093/hmg/ddaa172, doi:10.1093/hmg/ddaa172. This article has 27 citations and is from a domain leading peer-reviewed journal.

10. (solaveraUnknownyearfunctionalcharacterizationof pages 38-40): D Jové Solavera. Functional characterization of novel mutations in x-linked sideroblastic anaemia (xlsa) and the identification of transferrin receptor as a causative gene for a …. Unknown journal, Unknown year.

## Citations

1. schulz2024mechanismandstructural pages 1-3
2. steinhilper2024twostagebindingof pages 1-2
3. heffner2024tipofthe pages 2-4
4. jain2020assemblyofthe pages 15-16
5. jain2020assemblyofthe pages 3-4
6. jain2020assemblyofthe pages 2-2
7. jain2020assemblyofthe pages 9-10
8. jain2020assemblyofthe pages 19-20
9. 2Fe–2S
10. 1Fe–1S
11. 4Fe–4S
12. 2Fe-2S
13. 4Fe-4S
14. 4fe–4s
15. 2fe–2s
16. 2fe-2s
17. https://doi.org/10.1038/s41467-024-47310-8
18. https://doi.org/10.1038/s41467-024-54585-4
19. https://doi.org/10.20944/preprints202312.1414.v1
20. https://doi.org/10.1172/jci179559;
21. https://doi.org/10.1093/hmg/ddaa172
22. https://doi.org/10.1172/jci179559
23. https://doi.org/10.1172/jci179559,
24. https://doi.org/10.1038/s41467-024-47310-8,
25. https://doi.org/10.1038/s41467-024-54585-4,
26. https://doi.org/10.20944/preprints202312.1414.v1,
27. https://doi.org/10.1093/hmg/ddaa172,